MCRM
DXCM icon

Midway Capital Research & Management’s DexCom DXCM Stock Holding History

Midway Capital Research & Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5K Hold
200
– – 0.01% 92
2026
Q1 		$12.6K Buy
+200
New +$13.9K 0.01% 92

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Midway Capital Research & Management's DXCM Position: Q2 2026 in Review

Midway Capital Research & Management held its DexCom (DXCM) position steady in Q2 2026 at 200 shares worth $13.5K. The position accounts for 0.01% of the portfolio, ranked #92.

Midway Capital Research & Management first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Midway Capital Research & Management held 200 shares of DexCom worth $13.5K as of Q2 2026.
  • Midway Capital Research & Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.01% of Midway Capital Research & Management's portfolio in Q2 2026, its #92 holding.
  • Midway Capital Research & Management first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Midway Capital Research & Management's 13F filing for Q2 2026, filed 14 Jul 2026.